… prospective trial comparing gefitinib and erlotinib treatment. In this study, we retrospectively
… The aim of the study was to identify clinical predictors to assist physicians in selecting …

… study has several limitations as of the nature of retrospective design; our data suggest that
gefitinib and erlotinib … , although erlotinib appears to have higher toxicity than gefitinib at each …

… The purpose of this study was to compare clinical outcomes of Erlotinib versus Gefitinib in
the treatment of Asian patients with exon 19 EGFR-mutant lung adenocarcinoma and newly …

… In this retrospective, observational, multicentric study, we assessed effectiveness and
potentially response predictive factors in 222 unselected Italian patients, with stage IIIB/IV non-…

… this study was to evaluate the status of erlotinib … studies that have reported the ORR of
erlotinib in East Asian lung SCC patients. Studies that focused on efficacy of erlotinib after gefitinib …

… However, whether gefitinib, erlotinib, or afatinib is most appropriate as a first-line therapy is
… study was to compare the effectiveness of gefitinib, erlotinib, and afatinib. We retrospectively …

… In order to further evaluate the effectiveness between gefitinib and erlotinib, this study also …
PFS in erlotinib group (p=0.0162). This superiority of performance in erlotinib treatment group …

… Age 65 years and older was a risk factor for hepatotoxicity in the subgroup analysis of
NSCLC patients, which contrasted with our previous gefitinib study correlating younger age with …

… Afatinib had a superior tendency in terms of CNS-PFS, and cumulative incidence of CNS
failure compared with gefitinib or erlotinib. However, our study, as a retrospective study, has …

… differences between the gefitinib and erlotinib treatment groups in the present study. This …
of next-line chemotherapy in both groups (gefitinib group: 69.4%; erlotinib group: 69.2%). In …